AbbVie will contribute its Russian-related earnings to humanitarian relief efforts

Published on: 19 April 2022
7n70mucgwy3l0ijy 1645691721

AbbVie will donate all Russian sales profits to Ukraine relief efforts. We've stopped new clinical studies and enrollment in ongoing studies in Ukraine and Russia and suspended sales of our aesthetic products in Russia.

We are committed to doing everything possible to support the people of Ukraine and those impacted across the region. Our primary focus continues to be the safety of our colleagues and ensuring patients have access to the medicines they need.   As a company dedicated to the health of patients, we will continue to supply our essential life-saving medicines in Russia. Today, we are announcing that all profits from sales of AbbVie’s essential medicines in Russia will be donated to support direct humanitarian relief efforts in Ukraine.   In addition, we previously announced the suspension of all sales and distribution of our aesthetics products in Russia. We have also halted new clinical studies and ceased enrollment of ongoing studies in Ukraine and Russia.   Our work with nonprofit partners and employees to support humanitarian relief efforts in Ukraine will continue as we hope for a peaceful resolution.

For more information on our full response, visit https://www.abbvie.com/ukraine.html.

Source: AbbVie news

Share:
esg
esg
esg
esg
More from AbbVie Inc.
About 15,000 AbbVie employees will volunteer globally in Week of Possibilities
About 15,000 AbbVie employees will volunteer globally in Week of Possibilities
AbbVie Awards 45 Scholarships to U.S. Students Living with Chronic, Immune-Mediated Diseases in Their Pursuit of Higher Education
AbbVie Awards 45 Scholarships to U.S. Students Living with Chronic, Immune-Mediated Diseases in Their Pursuit of Higher Education
AbbVie opens application period for CF scholarship to celebrate 30th anniversary
AbbVie opens application period for CF scholarship to celebrate 30th anniversary